Recurrent Gastrointestinal Carcinoid Tumor Terminated Phase Trials for Motexafin lutetium (DB05296)

IndicationStatusPhase
DBCOND0028801 (Recurrent Gastrointestinal Carcinoid Tumor)TerminatedNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00087191EF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung CancerDiagnostic